Adtalem Global Education Inc.

and welcome to AdTalent's Global Education First Quarter Fiscal Year 2025 Earnings Call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note that this conference is being recorded. I will now turn the conference over to your host, Jay Spitzer, Vice President of Investor Relations. Thank you. You may begin.

Good afternoon, and welcome to our earnings call for the first quarter fiscal year 2025 results. On the call with me today are Steve Beard, President and Chief Executive Officer of AdTalent Global Education, and Bob Phelan, Chief Financial Officer. Before I hand you over to Steve, I will, as usual, take you through legal and safe harbor and cautionary declarations. Certain statements and projections of future results made in this presentation constitute as forward-looking statements that are based on current market competitive and regulatory expectations and are subject to risks and uncertainties that could cause actual results to vary materially. We undertake no obligation to update publicly any forward-looking statement after this presentation, whether a result of new information, future events, changes in assumption, or otherwise. Please see our latest Form 10-K, Form 10-Q for discussion of risk factors as they relate to forward-looking statements. In today's presentation, we use certain non-GAAP financial measures, refer you to the appendix of the presentation material available on our Investor Relations website for reconciliation to the most directly comparable GAAP financial measures and related information. You'll find a link to the webcast on our Investor Relations website at investors.adtalum.com. After this call, the presentation webcast will be archived on the website for 30 days. I will now hand you over to Steve. Thanks, Jay.

Good afternoon, everyone, and thank you for joining our first quarter fiscal year 2025 earnings call. We've commenced year two of our three-year growth with purpose strategy, which is driving strong momentum through a programmatic focus on operational excellence. This focus has enabled us to generate substantial value for all of our stakeholders and deliver financial results that exceed expectations. Our revenue for the quarter reached $417 million, reflecting a 13% increase compared to last year, while our adjusted EBITDA margin expanded by 140 basis points, leading to an impressive 39% jump in adjusted earnings per share to $1.29. Notably, total enrollment has improved for the 10th consecutive quarter, up 11.2% year over year, bringing our total enrollment to over 90,000 students. Our revitalized learning platform resonates well with our students, and our innovative curriculum enhances the student experience, positioning us at the forefront of healthcare education. Our agile operating model allows us to allocate resources efficiently and increase investments where we anticipate the most attractive returns. This model enables us to more quickly meet the growing and evolving demands of U.S. healthcare. with the goal of further differentiating ourselves as the preferred partner for healthcare providers nationwide. Recently, I had the privilege of speaking alongside Dr. Ngozi Ezike, President and CEO of Sinai Chicago. Sinai serves as a safety net health system for 1.5 million diverse individuals, many residing in under-resourced communities. Sinai aligns well with our mission to train day-one, practice-ready physicians equipped to deliver compassionate care. Through our partnership with Sinai Chicago, over 1,000 diverse aspiring medical students from Ross and AUC have participated in clinical rotations or residency programs, strengthening those students' commitment to and aptitude for battling health inequities. Numerous partnerships with other esteemed systems across the country highlight our reach and impact resulting in over 22,500 medical school alumni making meaningful contributions, often in critical leadership roles. Of course, this impact is further magnified by the outsized contributions of the nursing and behavioral health graduates of Chamberlain and Walden, who, working side by side with our physicians, elevate the quality of care for vulnerable populations across the country. Chamberlain University, a premier national nursing school, is enhancing its national footprint through a diverse array of nursing programs. Total enrollment increased 11.7% as Chamberlain surpassed its highest-ever total enrollment for the second consecutive year. Notably, our BSN online option is now available in 36 states with over 2,000 students enrolled just four years post-launch. Our new Stockbridge campus in Atlanta is exceeding expectations, achieving over 350 BSN students since opening last September. This growth demonstrates Chamberlain's commitment to leading the way in addressing chronic nursing shortages. We're also excited to announce a new partnership with the Oncology Nursing Society to expand our practice-ready, specialty-focused program to meet the increasing demand for specialized training in oncology. Turning to Walden, our market strategy with a focus on flexible distance learning for the working adult and our commitment to operational excellence continue to drive robust enrollment. which has grown 12.2% year-over-year, surpassing pre-pandemic levels. Our investments in cutting-edge technology attract students while enhancing retention. Walden remains a national leader in nursing, with over 16,000 nursing students currently enrolled, predominantly in the critical Master's Nurse Practitioner program. Furthermore, Enrollment in social and behavioral sciences exceeds pre-pandemic levels, reflecting strong interest in psychology, social work, and counseling. We continue to make strides in innovating the student experience through the implementation of AI capabilities. Last year, Chamberlain, leveraging Walden's AI learnings, launched its first AI tutor, Nurse Allie, which has received positive student feedback, leading to its rollout in additional programs. Moreover, Our recent collaboration with Hippocratic AI will develop groundbreaking curricula for training healthcare professionals in the use of AI technologies in care delivery, including the introduction of the first ever AI certification for our students. In our medical and veterinary segment, we see positive signs of improvement with Ross Vet operating at near capacity and ranked third among 40 institutions in the competitive veterinary internship and residency matching program. RossMed and AUC continue to demonstrate a strong value proposition, and initiatives like the Clinical Return Home Program are differentiating our offerings. Remediation plans at our two medical schools continue to progress as expected, and with strong and durable demand for medical education in the United States, we remain optimistic about future enrollment trends at both institutions. Fiscal year 2025 is off to a strong start, And we expect our growth with purpose strategy to deliver further growth in both revenue and profitability. With this positive momentum, we're raising our fiscal year 2025 guidance to project revenue between $1.69 billion and $1.73 billion and adjusted earnings per share of $5.75 to $5.95. Now I'll hand the call over to Bob for a more expansive discussion of our operational and financial results.